2 completed, 2 terminated, 1 active not recruiting, 1 unknown. 6 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Terminated 2, Active not recruiting 1, Unknown 1 |
| Phase 1 | 2 | Active not recruiting 1, Terminated 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Tazobactam: new trials by email Literature Review of Tazobactam trials Research Report on Tazobactam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn Patients Meropenem I.V. 2g as a 3 hour infusion every 8 hours, Tazocin (pipercillin/tazobactam) - Sepsis | Phase 1 / Phase 2 | Active not recruiting | Ain Shams University | 400 | 2024-01-01 | 2025-10-03 |
| Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam Cefepime, Ceftolozane, Laboratory Biomarker Analysis - Other Infectious Diseases | Phase 2 | Completed | M.D. Anderson Cancer Center | 100 | 2018-05-16 | 2022-03-15 |
| A Clinical Trial of YH1177 in Patients With Otitis Media and Otorrhea piperacillin 4% + tazobactam 0.5% + dexamethasone 0.1%, piperacillin 8% + tazobactam 1.0% + dexamethasone 0.1%, piperacillin 2% + tazobactam 0.25% - Otitis Media, Otorrhea | Phase 1 / Phase 2 | Terminated | Yuhan Corporation | 135 | 2016-06-01 | 2022-01-13 |
| Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis Intravenous Antibacterial Agent, Oral Antibacterial Agent - Osteomyelitis | Phase 2 | Terminated | Loyola University | 30 | 2014-03-19 | 2018-07-19 |
| Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections CXA-101/ tazobactam and metronidazole, meropenem plus saline placebo - Complicated Intra-abdominal Infection | Phase 2 | Completed | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 122 | 2010-06-25 | 2018-10-25 |
| Antibiotic Treatment in Ventilator Associated Tracheobronchitis (VAT) Piperacillin/Tazobactam for 7 days - Tracheobronchitis | Phase 2 / Phase 3 | Unknown | Assaf-Harofeh Medical Center | 100 | 2009-09-01 | 2009-12-09 |
Burns (1) · Diabetes Mellitus (1) · Osteomyelitis (1) · Otitis Media (1) · Sepsis (1)
Ain Shams University (1) · Assaf-Harofeh Medical Center (1) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · Loyola University (1) · M.D. Anderson Cancer Center (1) · Yuhan Corporation (1)
United States (3) · Argentina (1) · Egypt (1) · Georgia (1) · Israel (1) · Russia (1) · Serbia (1) · South Korea (1)
Arie Soroksky, MD (1) · Aya A Bayoumy, MD (1) · Ian Friedland, MD (1) · Issam I Raad (1) · Michael Pinzur, M.D. (1) · Mohamed A Ali, MD (1) · Osama R Abdelmalek, MD (1) · Thabet A Botros, MD (1)